Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01528878 · ClinicalTrials.gov registry record · NA
Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01528878 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 30 participants.
The verdict
NCT01528878, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine a tolerable dose of radiation delivered by the CyberKnife system in two groups of patients with hepatocellular carcinoma (HCC).
Interventions
- RADIATION Stereotactic Radiosurgery using the CyberKnife System.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-04 |
| Est. Completion | 2016-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01528878
The ClinicalTrials.gov registry entry for NCT01528878 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Radiosurgery using the CyberKnife System. is the first listed.
NCT01528878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01528878 about?
NCT01528878 is a clinical study titled "Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases". The purpose of this study is to determine a tolerable dose of radiation delivered by the CyberKnife system in two groups of patients with hepatocellular carcinoma (HCC).
What is the current status of trial NCT01528878?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2009-04. Estimated completion is 2016-01-28.
What interventions are being tested in trial NCT01528878?
The interventions under investigation include: Stereotactic Radiosurgery using the CyberKnife System. (RADIATION).
Who is sponsoring clinical trial NCT01528878?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.